Daniel A. Doyle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Daniel A. Doyle has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Becky Thomas
From the Division of Endocrinology, Department of Research, and the Division of Neurology, Nemours Children's Clinic-Wilmington, Alfred I. duPont Hospital for Children, Wilmington, Delaware. USA
1 shared publication- Brynn E. Marks
Division of Endocrinology and Diabetes, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
1 shared publication Eric Dumont
Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada
1 shared publication- Henrique Barbosa Ribeiro
Department of Interventional Cardiology, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
1 shared publication - Hugo De Larochellière
Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval Cardiac electrophysiology department 2725 Chemin Sainte-Foy, Québec (QC) G1V4G5, Canada
1 shared publication - Ignacio Jesús Amat Santos
Cardiology Department University Clinic Hospital of Valladolid Valladolid Spain
1 shared publication
Latest Publications
- 1 January 2016
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 29 (2) , 127-32
Idiopathic infantile hypercalcemia: case report and review of the literature
The widespread use of supplemental vitamin D has dramatically reduced the incidence of rickets. While generally considered a safe practice, there is potential for toxicity in patients with idiopathic infantile hypercalcemia (IIH). Inadequate 24-hydroxylase-enzyme activity renders these individuals unable to degrade active vitamin D, resulting in hypercalcemia due to increased intestinal calcium absorption, decreased renal calcium excretion, and increased osteoclastic bone activity. Clinicians should be aware that even therapeutic doses of vitamin D can prove harmful for patients with
- 1 January 2016
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 29 (2) , 127-32
Idiopathic infantile hypercalcemia: case report and review of the literature
The widespread use of supplemental vitamin D has dramatically reduced the incidence of rickets. While generally considered a safe practice, there is potential for toxicity in patients with idiopathic infantile hypercalcemia (IIH). Inadequate 24-hydroxylase-enzyme activity renders these individuals unable to degrade active vitamin D, resulting in hypercalcemia due to increased intestinal calcium absorption, decreased renal calcium excretion, and increased osteoclastic bone activity. Clinicians should be aware that even therapeutic doses of vitamin D can prove harmful for patients with
- 1 February 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (4) , 472-479
Effect on Outcomes and Exercise Performance of Anemia in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement
- 1 February 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (4) , 472-479
Effect on Outcomes and Exercise Performance of Anemia in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement
- Open Access
- 1 January 2012
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 25 (7-8) , 741-746
A novel mutation in the GCM2 gene causing severe congenital isolated hypoparathyroidism
To investigate the GCM2 gene in three siblings with congenital hypoparathyroidism and perform functional analysis. We sequenced the GCM2 gene by PCR and analyzed the functional consequence of the mutation by transient transfection studies. Haplotype analysis was performed. We identified a nucleotide change, c.408C>A, in exon 3 that is predicted to truncate the Gcm2 protein (p.Tyr136Ter). All three affected siblings were homozygous and both parents were heterozygous for the mutation. Transfection studies revealed the mutant mRNA but not expression of the Gcm2 protein. Haplotype analysis revealed that the two mutant GCM2 alleles shared genotypes on chromosome 6p24.2. We describe the first GCM2 mutation in exon 3 in patients with severe congenital hypoparathyroidism. Informative genetic markers could not exclude identity by descent for the mutant alleles. Gcm2 protein was not detected after transfection, suggesting that complete lack of Gcm2 action accounts for severe hypoparathyroidism.
- 1 January 2012
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 25 (7-8) , 741-746
Open AccessA novel mutation in the GCM2 gene causing severe congenital isolated hypoparathyroidism
To investigate the GCM2 gene in three siblings with congenital hypoparathyroidism and perform functional analysis. We sequenced the GCM2 gene by PCR and analyzed the functional consequence of the mutation by transient transfection studies. Haplotype analysis was performed. We identified a nucleotide change, c.408C>A, in exon 3 that is predicted to truncate the Gcm2 protein (p.Tyr136Ter). All three affected siblings were homozygous and both parents were heterozygous for the mutation. Transfection studies revealed the mutant mRNA but not expression of the Gcm2 protein. Haplotype analysis revealed that the two mutant GCM2 alleles shared genotypes on chromosome 6p24.2. We describe the first GCM2 mutation in exon 3 in patients with severe congenital hypoparathyroidism. Informative genetic markers could not exclude identity by descent for the mutant alleles. Gcm2 protein was not detected after transfection, suggesting that complete lack of Gcm2 action accounts for severe hypoparathyroidism.
- 1 August 2004
- Published by Elsevier in The Journal of Pediatrics
- Vol. 145 (2) , 190-193
Autosomal dominant transmission of congenital hypothyroidism, neonatal respiratory distress, and ataxia caused by a mutation of NKX2-1
- 1 August 2004
- Published by Elsevier in The Journal of Pediatrics
- Vol. 145 (2) , 190-193
Autosomal dominant transmission of congenital hypothyroidism, neonatal respiratory distress, and ataxia caused by a mutation of NKX2-1